Akèy › Lymphome de Hodgkin
Etid klinik pou Lymphome de Hodgkin ap rekrite nan Etazini
62 etid pou Lymphome de Hodgkin ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Houston, TX14 etid
- New York City, NY11 etid
- Baldwin Park, CA9 etid
- Boston, MA9 etid
- Miami, FL8 etid
- Memphis, TN7 etid
- Philadelphia, PA6 etid
- Mountain View, CA5 etid
- Greenburgh, NY5 etid
- Washington, DC4 etid
- Durham, NC4 etid
- Queens, NY4 etid
- Edison, NJ4 etid
- Aurora, CO4 etid
- Madison, WI4 etid
- Milwaukee, WI4 etid
- Atlanta, GA4 etid
- New Rochelle, NY3 etid
- East Norwalk, CT3 etid
- Staten Island, NY3 etid
- Denver, CO3 etid
- Cincinnati, OH3 etid
- Seattle, WA3 etid
- Chicago, IL3 etid
- Sacramento, CA3 etid
- Baltimore, MD3 etid
- Orange, CA3 etid
- Los Angeles, CA3 etid
- Indianapolis, IN3 etid
- San Francisco, CA3 etid
- Columbus, OH3 etid
- Minneapolis, MN3 etid
Pa eta
- Colorado5 etid
- Florid12 etid
- Georgia6 etid
- Illinois4 etid
- Indiana4 etid
- Kalifòni15 etid
- Maryland5 etid
- Massachusetts9 etid
- Minnesota4 etid
- New Jersey5 etid
- New York15 etid
- North Carolina6 etid
- Ohio4 etid
- Pennsylvania7 etid
- Tennessee8 etid
- Texas15 etid
- Washington4 etid
- Wisconsin8 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07285044Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Ap rekriteEtid obsèvasyon
Laj 18 a 120 · Tout sèks · Mizajou Sep 28, 2026 · NCT02682667Tissue Collection for Studies of Lymph Cancer
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT01676805Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT03418038Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT03618550Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06398457A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05615636Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Ap rekriteFaz 1
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05798897AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06137144Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT05272384Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07444632Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT06421987Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL
Ap rekriteFaz 2
Laj 2 a 21 · Tout sèks · Mizajou Aug 31, 2026 · NCT07551583Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Ap rekrite
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT07514819ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07021989CD45BE-HSPC + CART-45 Cells
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07451054Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
Ap rekriteFaz 1/2
Laj 12 a 80 · Tout sèks · Mizajou Aug 7, 2026 · NCT05092451ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT06090864Personalized NK Cell Therapy in CBT
Ap rekriteFaz 2
Laj 15 a 80 · Tout sèks · Mizajou Jul 30, 2026 · NCT02727803A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07020533A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT06150664Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Jul 20, 2026 · NCT06176690Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT06580002Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Ap rekriteFaz 3
Laj 16 a 69 · Tout sèks · Mizajou Jul 8, 2026 · NCT04685616A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.